title: Merck faces ongoing claims after Texan ruling on rofecoxib.
authors.forename: Janice Hopkins
authors.initials: JH
authors.lastname: Tanne
mesh_terms: D016861:Cyclooxygenase Inhibitors; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D007783:Lactones; D016365:Liability, Legal; D013450:Sulfones; D013781:Texas
chemical_list: D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib